Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Melanoma Res. 2011 Aug;21(4):298–307. doi: 10.1097/CMR.0b013e328344a003

Table 2.

Targets identified by integrative approach and validation

Gene Abbreviation Location CGH Loss % Median Tumor
Expression vs Nevi
Aza Fold
Upregulation
Chordin-like 1 CHRDL1 Xq23 −13.2 0.15 1.70
Secreted frizzled-related protein 1 SFRP1 8p12 −12.3 0.17 1.72
Transmembrane protein 47 TMEM47 Xp11 −13.5 0.08 1.29
Transcription factor 8 ZEB1 10p11 −20.8 0.33 1.85
Lipoprotein lipase LPL 8p22 −13.2 0.32 1.28
Retinoic acid receptor responder 1 RARRES1 3q25 −19.8 0.46 1.74
Phosphatidylinositol-specific
phospholipase C, X domain
containing 1
PLCXD1 Xp22 −16 0.41 1.32
Zinc finger protein 22 KOX 15 10q11 −24.5 0.43 1.29